echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Anesthesia Topics > Sci Tran med: Confirm the new target for analgesy.

    Sci Tran med: Confirm the new target for analgesy.

    • Last Update: 2020-10-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Genetic changes in the womb lay the foundation for the occurrence of pediatric kidney tumors.
    recently, a study published in the journal Science found that kidney cancer in children usually occurs in tissues that are prone to cancer during embryonic development.
    is the most common form of kidney cancer in children, mainly in children under 5 years of age.
    to track the origins of cancer, Sam Behjati and colleagues at the Wellcome Sanger Institute in Hinkston, UK, sequenced the genomes of tumor samples and non-cancerous kidney tissue.
    researchers found that in nearly two-thirds of children with Wilms tumors, cancer-related DNA mutations were present in both non-cancerous kidney tissue and tumor tissue.
    these mutations were not found in blood samples, suggesting that the changes occurred during kidney development and were not genetic.
    some children have Wilmsoma in their left and right kidneys.
    team found that in some of these cases, cancer occurs during embryonic development, before the cells that produce each kidney divide each other.
    results suggest that many tumors are caused by large amounts of tissue fragments that contribute to cancer, rather than by a small number of abnormal cells in normal tissue, the authors said.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.